PMID- 25422957 OWN - NLM STAT- MEDLINE DCOM- 20150803 LR - 20221207 IS - 1469-2198 (Electronic) IS - 0954-5794 (Print) IS - 0954-5794 (Linking) VI - 26 IP - 4 Pt 2 DP - 2014 Nov TI - Genetic moderation of child maltreatment effects on depression and internalizing symptoms by serotonin transporter linked polymorphic region (5-HTTLPR), brain-derived neurotrophic factor (BDNF), norepinephrine transporter (NET), and corticotropin releasing hormone receptor 1 (CRHR1) genes in African American children. PG - 1219-39 LID - 10.1017/S0954579414000984 [doi] AB - Genetic moderation of the effects of child maltreatment on depression and internalizing symptoms was investigated in a sample of low-income maltreated and nonmaltreated African American children (N = 1,096). Lifetime child maltreatment experiences were independently coded from Child Protective Services records and maternal report. Child depression and internalizing problems were assessed in the context of a summer research camp by self-report on the Children's Depression Inventory and adult counselor report on the Teacher Report Form. DNA was obtained from buccal cell or saliva samples and genotyped for polymorphisms of the following genes: serotonin transporter linked polymorphic region (5-HTTLPR), brain-derived neurotrophic factor (BDNF), norepinephrine transporter, and corticotropin releasing hormone receptor 1. Analyses of covariance with age and gender as covariates were conducted, with maltreatment status and respective polymorphism as main effects and their Gene x Environment (G x E) interactions. Maltreatment consistently was associated with higher Children's Depression Inventory and Teacher Report Form symptoms. The results for child self-report symptoms indicated a G x E interaction for BDNF and maltreatment. In addition, BDNF and triallelic 5-HTTLPR interacted with child maltreatment in a G x G x E interaction. Analyses for counselor report of child anxiety/depression symptoms on the Teacher Report Form indicated moderation of child maltreatment effects by triallelic 5-HTTLPR. These effects were elaborated based on variation in developmental timing of maltreatment experiences. Norepinephrine transporter was found to further moderate the G x E interaction of 5-HTTLPR and maltreatment status, revealing a G x G x E interaction. This G x G x E was extended by consideration of variation in maltreatment subtype experiences. Finally, G x G x E effects were observed for the co-action of BDNF and the corticotropin releasing hormone receptor 1 haplotype. The findings illustrate the variable influence of specific genotypes in G x E interactions based on variation in maltreatment experiences and the importance of a multigenic approach for understanding influences on depression and internalizing symptoms among African American children. FAU - Cicchetti, Dante AU - Cicchetti D AD - University of Minnesota Institute of Child Development. FAU - Rogosch, Fred A AU - Rogosch FA AD - University of Rochester Mt. Hope Family Center. LA - eng GR - R01 DA017741/DA/NIDA NIH HHS/United States GR - R01 MH083979/MH/NIMH NIH HHS/United States PT - Journal Article PL - United States TA - Dev Psychopathol JT - Development and psychopathology JID - 8910645 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Norepinephrine Plasma Membrane Transport Proteins) RN - 0 (Receptors, Corticotropin-Releasing Hormone) RN - 0 (SLC6A2 protein, human) RN - 0 (SLC6A4 protein, human) RN - 0 (Serotonin Plasma Membrane Transport Proteins) RN - 5CLY6W2H1M (CRF receptor type 1) SB - IM MH - Black or African American/*genetics/psychology MH - Anxiety/genetics/psychology MH - Brain-Derived Neurotrophic Factor/*genetics MH - Child MH - Child Abuse/*psychology MH - Depression/*genetics/psychology MH - Female MH - *Gene-Environment Interaction MH - Humans MH - Male MH - Norepinephrine Plasma Membrane Transport Proteins/genetics MH - Poverty MH - Receptors, Corticotropin-Releasing Hormone/genetics MH - Serotonin Plasma Membrane Transport Proteins/*genetics PMC - PMC4244663 MID - NIHMS620577 EDAT- 2014/11/26 06:00 MHDA- 2015/08/04 06:00 PMCR- 2015/11/01 CRDT- 2014/11/26 06:00 PHST- 2014/11/26 06:00 [entrez] PHST- 2014/11/26 06:00 [pubmed] PHST- 2015/08/04 06:00 [medline] PHST- 2015/11/01 00:00 [pmc-release] AID - S0954579414000984 [pii] AID - 10.1017/S0954579414000984 [doi] PST - ppublish SO - Dev Psychopathol. 2014 Nov;26(4 Pt 2):1219-39. doi: 10.1017/S0954579414000984.